Pharmacotherapy of Myelofibrosis.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1549, doi. 10.1007/s40265-017-0797-y
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2017 AND VI 77 AND IP 14
Results: 10
1
2
Drugs in Clinical Development for Fungal Infections.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1505, doi. 10.1007/s40265-017-0805-2
- By:
- Publication type:
- Article
3
Current and Emerging Options for the Management of Inherited von Willebrand Disease.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1531, doi. 10.1007/s40265-017-0793-2
- By:
- Publication type:
- Article
4
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1493, doi. 10.1007/s40265-017-0794-1
- By:
- Publication type:
- Article
5
Erratum to: A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1611, doi. 10.1007/s40265-017-0798-x
- By:
- Publication type:
- Article
6
Canagliflozin: A Review in Type 2 Diabetes.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1577, doi. 10.1007/s40265-017-0801-6
- By:
- Publication type:
- Article
7
Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1565, doi. 10.1007/s40265-017-0799-9
- By:
- Publication type:
- Article
8
Inotuzumab Ozogamicin: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1603, doi. 10.1007/s40265-017-0802-5
- By:
- Publication type:
- Article
9
Fampridine Prolonged Release: A Review in Multiple Sclerosis Patients with Walking Disability.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1593, doi. 10.1007/s40265-017-0808-z
- By:
- Publication type:
- Article
10
Pharmacotherapy of Anal Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 14, p. 1519, doi. 10.1007/s40265-017-0792-3
- By:
- Publication type:
- Article